S Abbara,Y Crabol,J Goupil de Bouillé et al.
S Abbara et al.
Artificial intelligence (AI) is set to permeate every facet of infectious disease practice-from prevention and public health surveillance to epidemic management and bedside care. Routine care data (laboratory results, medication orders, pro...
D Basille,Y Tandjaoui-Lambiotte,M Blot et al.
D Basille et al.
Over the past two decades, several studies have assessed the performance of lung ultrasonography in the diagnosis of community-acquired acute pneumonia (CAP). The performance of this diagnostic tool, when used by clinicians other than radio...
Antibiotic combination indications for the treatment of community-acquired acute pneumonia [0.03%]
社区获得性急性肺炎抗菌药物联合应用指征研究
Pierre Fillatre,Mathieu Blot,Damien Basille et al.
Pierre Fillatre et al.
Empirical dual combination therapy with beta-lactam and macrolide is often the standard treatment of community-acquired acute pneumonia (CAP) in adults hospitalized in non-intensive care units. However, several recent studies question this ...
Indications for corticosteroids in the treatment of Community-Acquired pneumonia [0.03%]
社区获得性肺炎治疗中糖皮质激素的使用指征
Mathieu Blot,Damien Basille,Aurélien Dinh et al.
Mathieu Blot et al.
Preceding guidelines on treatment and management of community-acquired pneumonia (CAP) do not endorse systematic use of corticosteroids. The data in the literature show contradictory results; while some have suggested clinical improvement i...
Aurélien Dinh,David Lebeaux
Aurélien Dinh
Previous guidelines have recommended 5-day antibiotic treatment for community-acquired pneumonia (CAP) patients manifesting clinical improvement after 48-72 h, and seven-day treatment for other, uncomplicated forms of CAP. Three meta-analys...
Towards more personalized management of pneumonia: recent progress and outstanding issues [0.03%]
肺炎的个性化管理：研究进展与悬而未决的问题
A Dinh,D Basille;working group
A Dinh
La prise en charge des pneumonies aiguës communautaires (PAC) continue d'évoluer, portée par les avancées diagnostiques et thérapeutiques récentes. Les recommandations françaises 2025 intègrent des changements majeurs: simplificatio...
Value of molecular biology tests in community-acquired acute pneumonia [0.03%]
社区获得性急性肺炎分子生物学检测的价值评估
V Cattoir,A Dinh,S Jarraud et al.
V Cattoir et al.
For patients hospitalized with community-acquired acute pneumonia (CAP), molecular tools (especially multiplex PCR syndromic panels) are associated with a significant improvement of microbiological diagnosis yield, compared with conventiona...
Bacterial epidemiology and antibiotic resistance rates in male urinary tract infections in France, 2019-2023 [0.03%]
2019-2023年法国男性泌尿系统感染的细菌流行病学和抗生素耐药率
Sophie Reissier,Malo Penven,Marlène Amara et al.
Sophie Reissier et al.
Aim: The aim of this study was to describe the bacterial epidemiology and antibiotic resistance rates of bacterial isolates collected from urine specimens in male patients with suspected urinary tract infection (UTI). ...
Amoxicillin/clavulanate activity against bacteria isolated in severe community-acquired pneumonia: a retrospective study (sCAP) [0.03%]
阿莫西林/克拉维酸对严重社区获得性肺炎分离细菌的体外活性：sCAP回顾性研究
A Sarr,M A Matta,F Kayembe et al.
A Sarr et al.
Background: Severe community-acquired pneumonia (sCAP) requires prompt empirical antibiotic therapy. Amoxicillin-clavulanate (AMC), an "Access" antibiotic per WHO AWaRe classification, could possibly constitute an ecologi...
J-P Lavigne,C Magnan,P Loubet et al.
J-P Lavigne et al.
Brucellosis is a reemerging zoonotic infectious disease caused by Brucella spp. and posing significant global health challenges. Focusing on epidemiology, pathophysiology, diagnostic tools, and therapeutic management, the present review syn...